Category: news

Quantinuum to Report Third Quarter Financial Results on November 5, 2026

BROOMFIELD, Colo., Oct. 22, 2026 /PRNewswire/ — Quantinuum Inc. (NASDAQ: QNT) (“Quantinuum”) today announced it will release its financial results for the third quarter ended September 30, 2026, on November 5, 2026, after market close. Quantinuum will host a conference call at 5:00 PM Eastern time that same day...

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to $1.1 billion, plus royalties. FLORENCE, Italy and GAITHERSBURG, Md., Oct. 22, 2026 /PRNewswire/...

Frost & Sullivan: Total Airport Management Market to More than Double to $10.36 Billion by 2034 as Airports Integrate Operations Data

With passenger traffic heading toward twice today’s levels and little room for new runways, airports are connecting people, processes and technology into a single operating picture. CUPERTINO, Calif., Oct. 22, 2026 /PRNewswire/ — Airports face a capacity challenge that new construction alone cannot solve, with global passenger traffic expected...

Ford Foundation Charts New Course to Support Preconditions for Thriving Democracies

New strategy will refocus the foundation’s mission to protect and strengthen democratic values, fundamental freedoms, and inclusive economies worldwide NEW YORK, Oct. 22, 2026 /PRNewswire/ — The Ford Foundation today unveiled its new strategic direction to support the preconditions necessary for democracies to thrive. The foundation will refocus its...

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to $1.1 billion, plus royalties. FLORENCE, Italy and GAITHERSBURG, Md., Oct. 22, 2026 /PRNewswire/...